Total planned funding: $304,732,344
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $67,374,274 |
Kenya | $54,401,883 |
Mozambique | $46,835,537 |
South Africa | $21,151,877 |
Vietnam | $15,915,065 |
Tanzania | $13,329,119 |
Ethiopia | $12,229,711 |
Haiti | $10,025,000 |
Rwanda | $9,225,501 |
Zimbabwe | $8,990,190 |
Burundi | $8,135,632 |
Côte d'Ivoire | $6,335,119 |
Cambodia | $4,728,160 |
Zambia | $4,548,998 |
Uganda | $4,301,714 |
Malawi | $3,760,663 |
Democratic Republic of the Congo | $3,168,286 |
Botswana | $3,073,386 |
India | $2,626,000 |
China | $1,985,110 |
Eswatini | $1,530,187 |
Lesotho | $653,628 |
Thailand | $407,304 |
Namibia | $0 |
South Sudan | $0 |
Organizational Types
NGO | $304,732,344 |
Program Areas
Care | $98,423,577 |
Treatment | $86,751,463 |
Prevention | $80,183,195 |
Governance and Systems | $21,889,117 |
Testing | $17,484,992 |
Budget Codes
HTXS: Treatment: Adult Treatment | $63,339,813 |
HKID: Care: Orphans and Vulnerable Children | $60,353,125 |
HVOP: Sexual Prevention: Other Sexual Prevention | $40,885,249 |
HBHC: Care: Adult Care and Support | $28,714,503 |
HVCT: Testing: HIV Testing and Counseling | $17,484,992 |
HTXD: Treatment: ARV Drugs | $16,910,934 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,878,776 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,552,789 |
HLAB: Laboratory Infrastructure | $9,347,103 |
HVSI: Strategic Information | $7,749,973 |
PDTX: Treatment: Pediatric Treatment | $6,500,716 |
HVTB: Care: TB/HIV | $5,167,934 |
OHSS: Health Systems Strengthening | $4,792,041 |
PDCS: Care: Pediatric Care and Support | $4,188,015 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,814,385 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,585,019 |
HMIN: Biomedical Prevention: Injection Safety | $318,974 |
HMBL: Biomedical Prevention: Blood Safety | $148,003 |